Michael Ladna

Michael Ladna practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Michael Ladna's NPI, 1245767854, was assigned on May 12, 2017. Michael Ladna graduated from Jagiellonian University Medical College in 2017. Michael Ladna holds California license A186204.

Michael Ladna's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Michael Ladna's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Ladna practices. Vendor and product names are available with a free account.

Internal medicine is Michael Ladna's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Michael Ladna is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Michael Ladna's licenses on file in 2 states: California and Florida.

Dmand AI lists sepsis among the conditions Michael Ladna treats.

CMS data shows 373 Medicare services from Michael Ladna across 5 procedure codes in 2024, for 199 Medicare patients. Medicare paid $32,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Michael Ladna in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 50% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Ladna's median patient age at 57, with 44% women.

In 2024, Michael Ladna wrote 413 Medicare Part D claims for 61 patients. 80% of them were for generic drugs. CMS names the drug for 200 of them, across 12 drugs with 11 or more claims each, at $28,719 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Michael Ladna for performance year 2024, reported as part of a group. Michael Ladna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Michael Ladna, published from 2020 to 2025. 2024 was the busiest year, with 8. Michael Ladna has published most often in Cureus. Michael Ladna's most frequent co-authors are John Nadayil George, MD, Christopher E. Forsmark, MD and Adnan Bashir Bhat, MD.

CMS Open Payments shows 1 general payment to Michael Ladna from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Ferring Pharmaceuticals Inc. paid the most, $92.

Michael Ladna graduated from Jagiellonian University Medical College in 2017.

Michael Ladna is in network with 10 carriers, including Excellus BlueCross BlueShield, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.